First Eagle Investment Management LLC Buys 501,035 Shares of Haleon plc (NYSE:HLN)

First Eagle Investment Management LLC boosted its stake in shares of Haleon plc (NYSE:HLN) by 36.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,862,056 shares of the company’s stock after buying an additional 501,035 shares during the quarter. First Eagle Investment Management LLC’s holdings in Haleon were worth $15,381,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Cultivar Capital Inc. bought a new stake in Haleon in the second quarter valued at approximately $40,000. Allspring Global Investments Holdings LLC bought a new stake in shares of Haleon in the 1st quarter valued at $43,000. GAMMA Investing LLC increased its position in shares of Haleon by 151.3% during the first quarter. GAMMA Investing LLC now owns 6,106 shares of the company’s stock worth $52,000 after buying an additional 3,676 shares during the period. Pinnacle Bancorp Inc. increased its position in shares of Haleon by 29.8% during the first quarter. Pinnacle Bancorp Inc. now owns 6,188 shares of the company’s stock worth $53,000 after buying an additional 1,421 shares during the period. Finally, Hexagon Capital Partners LLC raised its stake in Haleon by 66.6% during the second quarter. Hexagon Capital Partners LLC now owns 6,695 shares of the company’s stock worth $55,000 after buying an additional 2,677 shares during the last quarter. Institutional investors own 6.67% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on HLN shares. The Goldman Sachs Group cut shares of Haleon from a “buy” rating to a “neutral” rating in a research report on Tuesday, August 6th. Berenberg Bank began coverage on Haleon in a research report on Tuesday, August 6th. They set a “buy” rating on the stock. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.

Haleon Stock Performance

NYSE:HLN opened at $10.56 on Thursday. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. Haleon plc has a twelve month low of $7.70 and a twelve month high of $10.76. The company has a fifty day moving average of $9.66 and a 200-day moving average of $8.83. The firm has a market capitalization of $48.22 billion, a P/E ratio of 35.20, a P/E/G ratio of 3.10 and a beta of 0.26.

Haleon (NYSE:HLN) last posted its quarterly earnings results on Thursday, August 1st. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.01). The company had revenue of $3.50 billion during the quarter, compared to the consensus estimate of $3.55 billion. Haleon had a net margin of 9.71% and a return on equity of 13.15%. During the same period last year, the firm posted $0.08 earnings per share. As a group, sell-side analysts anticipate that Haleon plc will post 0.46 EPS for the current year.

Haleon Cuts Dividend

The company also recently declared a semi-annual dividend, which will be paid on Thursday, September 19th. Investors of record on Friday, August 16th will be paid a dividend of $0.0514 per share. This represents a yield of 1.6%. The ex-dividend date of this dividend is Friday, August 16th. Haleon’s dividend payout ratio (DPR) is currently 33.33%.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.